home / stock / roiv / roiv quote
Last: | $10.48 |
---|---|
Change Percent: | -0.76% |
Open: | $10.66 |
Close: | $10.56 |
High: | $10.68 |
Low: | $10.45 |
Volume: | 2,341,182 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.48 | $10.66 | $10.56 | $10.68 | $10.45 | 2,341,182 | 07-03-2024 |
$10.56 | $10.83 | $10.56 | $10.83 | $10.475 | 4,434,961 | 07-02-2024 |
$10.83 | $10.5 | $10.83 | $10.89 | $10.5 | 4,128,756 | 07-01-2024 |
$10.57 | $10.575 | $10.57 | $10.75 | $10.44 | 11,362,892 | 06-28-2024 |
$10.57 | $10.53 | $10.57 | $10.62 | $10.405 | 4,480,328 | 06-27-2024 |
$10.57 | $10.76 | $10.57 | $10.82 | $10.54 | 3,249,961 | 06-26-2024 |
$10.83 | $10.87 | $10.83 | $11.02 | $10.73 | 4,397,449 | 06-25-2024 |
$10.91 | $10.71 | $10.91 | $10.99 | $10.7 | 10,111,365 | 06-24-2024 |
$10.69 | $10.9 | $10.69 | $10.92 | $10.57 | 19,405,106 | 06-21-2024 |
$10.8 | $10.8 | $10.8 | $10.895 | $10.74 | 5,166,466 | 06-20-2024 |
$10.84 | $10.74 | $10.84 | $10.865 | $10.68 | 3,955,265 | 06-19-2024 |
$10.84 | $10.74 | $10.84 | $10.865 | $10.68 | 3,955,265 | 06-18-2024 |
$10.72 | $10.64 | $10.72 | $10.815 | $10.6 | 2,693,939 | 06-17-2024 |
$10.69 | $10.71 | $10.69 | $10.775 | $10.585 | 2,802,689 | 06-14-2024 |
$10.81 | $10.76 | $10.81 | $10.92 | $10.705 | 2,893,789 | 06-13-2024 |
$10.83 | $10.86 | $10.83 | $10.93 | $10.71 | 4,458,420 | 06-12-2024 |
$10.57 | $10.48 | $10.57 | $10.67 | $10.4 | 3,654,654 | 06-11-2024 |
$10.58 | $10.33 | $10.58 | $10.6 | $10.25 | 5,049,981 | 06-10-2024 |
$10.47 | $10.53 | $10.47 | $10.635 | $10.36 | 4,694,549 | 06-07-2024 |
$10.62 | $10.86 | $10.62 | $10.9 | $10.52 | 3,662,214 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report its financial results for the fourth quarter and fiscal year ended March 31...